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Abstract Evidence is accumulating that membrane traffic
between organelles can be achieved by different types of
intermediates. Small (6 100 nm) and short-lived vesicles mediate
transport from the plasma membrane or the trans-Golgi network
to endosomes, and formation of these vesicles depends on specific
adapter complexes. In contrast, transport from early to late
endosomes is achieved by relatively large (V0.5 Wm), long-lived
and multivesicular intermediates, and their biogenesis depends on
endosomal COP-I proteins. Here, we review recent work on the
formation of these different transport intermediates, and we
discuss, in particular, coat proteins, sorting signals contained in
cargo molecules and the emerging role of lipid in vesicle
biogenesis.
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1. Introduction
The endocytic pathway is responsible for the internaliza-
tion, recycling and degradation of extracellular material, and
the turnover of cell surface components [1,2]. Internalized
solutes, lipids and proteins ¢rst appear in early endosome,
and then recycle back to the plasma membrane for reutiliza-
tion, or are targeted to late endosomes and eventually lyso-
somes for degradation (see outline Fig. 1). Protein tra⁄cking
from the cell surface to lysosomes involves distinct steps of
protein sorting and occurs via di¡erent types of vesicular in-
termediates.
Selective protein transport from plasma membrane to early
endosomes is mediated by small (6 100 nm diameter) and
short-lived (V1 min) vesicles coated with clathrin and the
AP2 adapter complex [3]. The majority of internalized mole-
cules are recycled back to the cell surface, whereas a small
fraction, including down-regulated cell surface receptors, is
selectively incorporated within transport intermediates des-
tined for late endosomes [1,2]. These intermediates, which
will be referred to here as endosomal carrier vesicles (ECVs)
[4^6], are relatively large (V0.5 Wm) and long-lived (V15^30
min) vesicles with a multivesicular appearance, in contrast to
AP2/clathrin-coated vesicles. ECV biogenesis depends on pro-
teins which belong to the COP-I coat, previously known to be
involved in the early secretory pathway [7]. Protein transfer
from late endosomes to lysosomes may occur via a di¡erent
mechanism involving the transient formation of a hybrid or-
ganelle [8,9].
Endosomes are also connected to the biosynthetic pathway
via selective transport routes. Vesicles coated with clathrin
associated with the AP1 adapter complex mediate delivery
of newly synthesized lysosomal enzymes and lysosomal pro-
teins from the trans-Golgi network (TGN) to endosomes, as
well as perhaps AP3-coated vesicles [10,11]. Protein recycling
back to the TGN occurs from late endosomes [12], as well as
perhaps from early endosomes [13]. The di¡erent types of
transport intermediates and coat proteins involved during
transport toward lysosomes from the cell surface or from
the TGN will be discussed further in this review.
2. Clathrin-coated vesicles at the plasma membrane
At the cell surface, molecules destined to be internalized
cluster within plasma membrane invaginations coated with
clathrin and the AP2 adapter (coated pits). These invagina-
tions pinch o¡ from the membrane, become free vesicles, and
fuse with early endosomes, thereby delivering the internalized
cargo of solutes, proteins and lipids. It is generally accepted
that the coat is responsible for the sorting of internalized
proteins, and that its polymerization contributes to the invag-
ination process. The AP2 adapter is a heterotetrameric com-
plex, containing two V100 kDa proteins (K, L2 adaptins), a
V50 kDa chain (W2) and a small chain of V20 kDa (c2) [3].
AP2 can interact directly with Tyr-based or di-Leu motifs
present in the cytoplasmic domains of cell surface receptors,
thereby allowing their selective incorporation within forming
coated pits [14]. Recruitment of AP2 on the plasma membrane
may depend, at least in part, on interactions with cell surface
receptors via these sorting signals. Expression of the trans-
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Fig. 1. Transport intermediates in the endocytic pathway. Major
routes of membrane transport are outlined, and transport intermedi-
ates are indicated. 1: Clathrin/AP2-coatedvesicles; 2: clathrin/AP1-
coated- esicles; 3: AP3-coated vesicles, presumably involved in
transport from the TGN to endosomes/lysosomes; 4: endosomal
carrier vesicles. Abbreviations: pm, plasma membrane; EE, early
endosome; RE, recycling endosome; LE, late endosome; LYS, lyso-
some; TGN; trans-Golgi network; GC, Golgi complex.
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ferrin (Tf) receptor, which contains a Tyr-based internaliza-
tion signal, promotes formation of a clathrin lattice, even
though invaginated pits do not form [15]. Overexpression of
chimeric proteins containing cytoplasmic domains with classi-
cal internalization signals to saturation level does not induce
coated pit formation [16]. However, overexpression of HIV-1
viral Nef protein causes the assembly of clathrin-coated pits,
but speci¢c for CD4/Nef [17]. In contrast to membrane bind-
ing of AP1, AP3 and COP-I, AP2 assembly at the plasma
membrane is not stimulated by GTPQS and does not depend
on ARF1 [18,19]. In the presence of GTPQS, however, AP2 is
recruited by endosomes in a process mediated by ARF1 and
phospholipase D [20,21].
The precise mechanisms responsible for speci¢c assembly of
AP2/clathrin at the plasma membrane are still not clear, but
new insights are expected from recent studies, which have
uncovered new components of the clathrin/AP2 coat. A sub-
strate of the EGF receptor tyrosine kinase, Eps15, was re-
cently found to be constitutively associated with coated pits
and is required for EGF and Tf internalization [22^26]. Epsin,
which binds the EH domain of Eps15, may be another new
component of the clathrin machinery, since epsin disruption
blocks clathrin-mediated endocytosis [27]. After AP2 binding,
clathrin molecules are recruited through interactions between
the ear domain of AP2 and the clathrin triskelion legs, driving
clathrin assembly [28], as con¢rmed by the structure of the
clathrin coat at 21 Aî resolution [29]. Once the clathrin/AP2
coat is assembled, the GTPase dynamin is required for ¢ssion
of the vesicle from the plasma membrane [30]. GDP/GTP
exchange leads to the self-assembly of the dynamin polymers
which are thought to form a collar around the neck of the
coated pit, GTP hydrolysis then providing the driving force
for neck constriction and vesicle ¢ssion.
3. Clathrin-coated vesicles at the TGN
Clathrin-coated vesicles also form on the TGN, and are
responsible for the sorting and transport of newly synthesized
lysosomal hydrolases bound to the mannose 6-phosphate re-
ceptors (MPRs) towards endosomes [11,12]. These vesicles
have the same morphological appearance as those present at
the plasma membrane, but di¡er in composition, the clathrin
lattice being associated with the AP1 adapter complex (Q, L1,
W1 and c1). Unlike AP2, the binding of AP1 to TGN is
mediated by ARF1, blocked by brefeldin A and enhanced
by GTPQS [31].
AP1 recruitment onto TGN membranes was proposed to
depend on MPRs, well characterized cargo molecules of
TGN-derived clathrin/AP1-coated vesicles. Knock-out of
MPRs in mice decreases AP1 binding onto TGN membranes
[32], and binding is restored upon MPR re-expression [33].
However, it is not clear at present whether high a⁄nity sites
for AP1 binding are provided by MPR itself [32], ARF1 [34],
or both. Recent studies also suggest that MPRs are not essen-
tial determinants in the initial AP1 binding step, but may play
a regulatory role in clathrin-coated vesicle formation by af-
fecting ARFWGTP hydrolysis [35]. Further work will be re-
quired to characterize the precise mechanisms responsible
for AP1 localization to TGN membranes, much like for
AP2 at the plasma membrane.
Clathrin assembly after AP1 binding is believed to occur in
a process similar to clathrin/AP2 assembly. Fission of AP1/
clathrin-coated vesicles may also depend on dynamin, as for
AP2/clathrin-coated vesicles. Dynamin was found associated
with the TGN [36,37], and antibodies against dynamin or
dynamin-depleted cytosol inhibited clathrin/AP1 vesicle for-
mation in vitro [38].
4. AP3
Recently, a new adapter-related protein complex, AP3, has
been identi¢ed, both in mammals and in yeast [39^42]. Similar
to AP1 and AP2, the AP3 adapter is a heterotetramer (N, L3,
W3 and c3). Studies in yeast showed that AP3 is involved in
direct transport of alkaline phosphatase and Vam3p from a
post-Golgi compartment to the vacuole [42^44]. However, the
precise function of AP3 in higher eukaryotic cells is not clear
yet. A homologue of AP3 N adaptin has been found in Dro-
sophila [45,46]. In mouse the mocha gene encodes N AP3 adap-
tin and the pearl gene is probably the L3 adaptin homologue
[47]. Disruption of these genes results in pigmentation defects
and/or heavy bleeding, presumably due to defective biogenesis
of lysosome-related organelles, such as melanosomes and
platelet dense granules.
Much like AP1, but unlike AP2, AP3 membrane binding is
sensitive to brefeldin A and enhanced by GTPQS, and requires
ARF1 in vitro [48]. Whether AP3 is associated with clathrin is
still a matter of debate [39^41]. Membrane proteins destined
for late endosomes-lysosomes which can interact with the AP3
adapter have been identi¢ed. Although earlier studies sug-
gested that Lamp1 may be incorporated into AP1-coated
vesicles [49], it was recently shown that Lamp1 and LIMP-
II overexpression promoted membrane binding of AP3, and
inactivation of AP3 caused Lamp1 and LIMP-II mistargeting
[50]. Consistent with these observations, mistargeting of the
lysosomal proteins CD63, Lamp1, and Lamp2 was observed
in ¢broblasts from patients with Hermansky-Pudlak syn-
drome who carry mutations in the L3A subunit of AP3 [51].
AP3 was also shown to interact with the cytoplasmic tails of
the LIMP-II and melanosome-associated protein tyrosinase in
vitro, and the binding was dependent on a di-Leu sequence in
both proteins [52]. These data collectively suggest that AP3 in
mammalian cells is likely to be involved between TGN and
lysosomes, similarly to the Golgi-vacuole pathway in yeast.
However, AP3 has also been implicated in synaptic vesicle
formation from endosomes [53], suggesting that AP3 may be
required at more than one transport step.
5. ECVs and COP-I
ECVs exhibit a characteristic multivesicular appearance,
and accumulation of internal membranes appears to be
coupled to the organization/dynamics of early endosomes
[54,55]. Once formed, ECVs are transported towards late en-
dosomes in a process which requires intact microtubules and
motor proteins [5,6], in contrast to clathrin-coated vesicles.
Then, they fuse with late endosomes [5,6], and docking/fusion
depends on NSF, KSNAP, as well as perhaps another AAA
ATPase [56] and the small GTPase rab7 [57].
Protein motifs which function as endosome/lysosome-tar-
geting signals have been identi¢ed, but it is often not clear
whether these signals operate within endosomes, or at earlier
transport steps [1,2,14]. However, an eight amino acids motif
in the interleukin-2 receptor L chain was shown to determine
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its transport from early to late endosomes (and lysosomes)
[58,59]. Recent studies also revealed that HIV Nef contains
two acidic amino acids critical for CD4 down-regulation,
which operate within early endosomes and mediate speci¢c
interactions with endosomal LCOP [60]. Acidic clusters have
previously been reported to function as intracellular sorting or
localization signals [61^64].
In vivo and in vitro studies have shown that endosomal
COP-I coat proteins are involved in ECV biogenesis and
play a role in protein sorting [55,60,65^67]. The COP-I sub-
units are present as a protein complex termed the coatomer,
including in the cytosol [7,68]. The coatomer is formed by
seven polypeptides, K, L, LP, Q, N, O and jCOP, and is known
to be also involved at early steps of the biosynthetic pathway
[7]. Binding of COP-I to biosynthetic [69] and endocytic (F.
Gu and J. Gruenberg, unpublished) membranes is regulated
by the small GTP binding protein ARF1. However, endoso-
mal and biosynthetic COPs exhibit di¡erent properties.
Endosomal and biosynthetic COPs appear to di¡er in com-
position, since Q and NCOP subunits are not detected on endo-
somes, in contrast to biosynthetic membranes [65,66]. After
OCOP degradation in the ldlF cell line, which carries a temper-
ature-sensitive mutation in the OCOP gene [70], KCOP no
longer binds endosomes but is still recruited onto biosynthetic
membranes [55], consistent with observations that KCOP sta-
bilizes OCOP in yeast [71]. Endosomal and biosynthetic COPs
also di¡er in their biochemical properties. Neutralization of
the endosomal pH inhibits ECV biogenesis in vitro [55,66],
transport from early to late endosomes in vivo and in vitro
[54,72], as well as transport to lysosomes [73]. Then, COP
binding to endosomal, but not biosynthetic, membranes is
inhibited [55,66], and ARF1 appears to regulate this process
(F. Gu and J. Gruenberg, unpublished). COP assembly onto
endosomes may thus be regulated by a trans-membrane pH
sensor, thereby signaling the onset of the degradation path-
way on early endosomal membranes [66]. Recent studies in-
dicate that a pH-dependent mechanism is also involved during
retrograde transport in the early secretory pathway [74], but
this process does not appear to depend on a pH-sensitive COP
binding step [55,66,74].
At present little is known about the direct role of endo-
somal COPs in protein sorting. Inactivation of COPs in the
ldlF cells at the restrictive temperature [70] a¡ects Tf receptor
recycling to the cell surface [67], but not bulk recycling [55].
Similarly, neutralization of the endosomal pH retards Tf re-
ceptor recycling more than bulk membrane recycling. Endo-
somal COPs may play a role in Tf receptor sorting, but these
e¡ects may also result from early endosome disorganization
after COP inactivation or pH neutralization [54,55]. More
directly, COPs were recently shown to play a role in the sort-
ing of down-regulated HIV-Nef/CD4 complex in early endo-
somes [60].
A working model for the membrane association of endo-
somal COPs is outlined in Fig. 2. Acidi¢cation causes a con-
formational change in the putative pH sensor, which then
allows ARF1-GTP recruitment onto early endosome, and
then endosomal COP-I are recruited by ARF1-GTP. A func-
tional dissection of endosomal COPs using cytosol from ldlF
cells incubated at the restrictive temperature indicates that the
L, LP and j subunits can become membrane-associated in the
absence of K and O (and Q and N, which are normally not
detected on endosomes) [55]. It is unlikely that endosomal
COPs bind membranes as a partial coatomer complex (lacking
the Q and N subunits), since coatomer subcomplexes have not
been found [75]. Alternatively, the complete coatomer may be
recruited as a single unit, followed by rapid dissociation of
Q and N subunits, uncovering sites for speci¢c interactions with
cargo molecules, or functional equivalents of the Q and/or
N subunits associated with endosomal COPs may remain to
be discovered. Finally, endosomal COPs may interact with
Nef and/or other cargo molecules destined to be incorporated
into forming ECVs.
Fig. 2. Membrane recruitment of endosomal COPs. This model represents three steps presumably involved in endosomal COP membrane re-
cruitment. 1: A transmembrane pH sensor regulates the binding of ARF1 onto the membrane. 2: ARF1 drives the binding of a speci¢c set of
endosomal COPs (K, L, LP, O, j); the N and Q subunits are not detected on endosomes). 3: Endosomal COPs recognize speci¢c sorting motifs
on cargo molecules as shown for HIV Nef/CD4, and mediate protein sorting and ECV formation.
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6. Lipids and vesicle formation
Lipid-protein interactions in the endocytic pathway will be
brie£y mentioned here, since the possible roles of lipids and
lipid metabolism in membrane tra⁄c have been reviewed re-
cently [76^79]. The neuronal protein synaptojanin, involved in
synaptic vesicle recycling, is a PI(3,4,5)P3 5-phosphatase [80],
and K adaptin (AP2) interacts with PI(3,4,5)P3 [81]. Interac-
tions of W2 (AP2) with Tyr-based signal are increased by
phosphoinositides phosphorylated in the D-3 position [82].
In contrast, interactions between the di-Leu motif and L1
(AP1) are inhibited by PI(3,4)P2 or PI(3,4,5)P3 [83]. Dynamin
interacts with PI(4,5)P2, thereby stimulating GTPase activity
and promoting self-assembly [84,85]. Clathrin can polymerize
onto liposomes, as does dynamin-1 with GTP hydrolysis then
driving vesiculation [86,87]. Although it is too early to draw
general models on lipid involvement in vesicle formation,
these observations show that lipids, in particular signaling
lipids, are regulators of various proteins involved in vesicle
formation and molecular sorting.
It is not clear at present whether signaling lipids are in-
volved in ECV biogenesis in mammalian cells. In yeast cells,
however, phosphoinositides were reported to play a role in
protein sorting in the multivesicular body [88]. In addition,
COP-I recruitment onto Golgi membranes was proposed to
depend on the local production of phosphatidic acid via
ARF1-mediated phospholipase D activation [78], but the pos-
sible role of phospholipase D in ECV biogenesis is not known.
Whereas little is known about signaling lipids, evidence is
accumulating that internalized lipids do not distribute as
bulk constituents of the bilayer, but that di¡erent lipids are
selectively transported along recycling and degradation path-
ways, much like proteins [79]. Early and late endosomes also
di¡er in lipid composition, and late endosomes contain high
amounts of the unique lipid lyso-bisphosphatidic acid [89].
This lipid distributes exclusively within late endosome internal
membranes, and is involved in protein sorting/tra⁄cking with-
in late endosomes [89]. Since lyso-bisphosphatidic acid is not
detected in early endosomes, it is unlikely to be involved in
ECV biogenesis. However, the fact that only some, but not
all, internalized lipids are incorporated within forming ECVs
suggests that these exhibit biophysical properties, including
perhaps length and saturation of acyl chains [90], which con-
tribute to the local deformation and subsequent invagination
of membranes within forming ECVs.
7. Conclusions
Di¡erent types of intermediates ensure intracellular mem-
brane £ow along the endocytic pathway. Basic principles of
protein sorting and membrane tra⁄cking are shared by these
intermediates (e.g. coat proteins), but di¡erences exist in the
molecular mechanisms (e.g. regulating coat association) (see
Table 1). It is generally accepted that small, short-lived
vesicles (i.e. clathrin-coated) provide the most e⁄cient means
to transport membrane constituents. ECVs, in contrast, are
much larger, yet contain high amounts of internal mem-
branes; it has not been possible to determine the surface
area of internal membranes until now. Unlike AP-coated
vesicles, ECVs, however, mediate microtubule-dependent
transport over long intracellular distances, from peripheral
early endosomes to perinuclear late endosomes [4^6], includ-
ing from the tip of the axon the cell body in neurons [91].
ECV biogenesis may thus provide e⁄cient membrane pack-
aging in order to achieve optimal and cost-e⁄cient long dis-
tance transport in the endosomal system.
The fact that COP inactivation leads to a disappearance of
multivesicular domains from early endosomes [55] suggests
that COPs directly participate in the process leading to the
characteristic accumulation of internal membranes within
forming ECVs. COP proteins may also be involved in mem-
brane organization in the biosynthetic pathways, in addition
to their known functions in protein sorting and vesicle for-
mation, since COP inactivation in the ldlF mutant cell line at
the restrictive temperature also leads to a disruption of Golgi
organization [92]. The precise mechanisms leading to the in-
vagination of internal membranes within forming ECVs are
still not known. However, proteins and lipids are selectively
incorporated within forming ECVs, in a process presumably
facilitated by endosomal COPs. One may speculate that pro-
tein sorting and selective lipid partitioning within early endo-
somal membranes contribute to the association of some com-
ponents within membrane regions or domains, which favor
inward deformation of the membrane and then invagination,
eventually leading to a forming ECV.
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Table 1
Membrane binding properties of coat proteins
AP1 AP2 AP3 End COP Golgi COP
ARF1 + [31] no (mis-loc) [21] + [48] +a + [93]
PLD, PA n.d. no (mis-loc) [21] n.d. n.d. + [94]
Lumenal pH n.d. ^ n.d. 3 [55,66] no [55,74]
Sorting motifs diLeu, Tyr [95] Tyr diLeu [95] diLeu Tyr [52,96] diGlu HIV-Nef [60] KKXX, FF [68]
Subunits involved W1/Tyr [96] W2/Tyr [82] W3/Tyr [96] LCOP/diGlu, Nef [60] K,L,O/KKXX [68]
W2/diLeu [99] Q/KKXX [97]
L1/diLeu [83] L2/diLeu [100] L,Q,j/FF [98]
PIs with D3 phosphate 3 + n.d. n.d. n.d.
L1/diLeu [83] W2 /Tyr [82]
The table summarizes information on properties of coat proteins in the endocytic pathway. Greek letters refer to subunits of adapters and
COPs (see text). Abbreviations: mis-loc: AP2 mis-localization to endosomes; +: stimulated; 3 : inhibited; no: no e¡ect; n.d. not determined;
diLeu: di-Leu-based sorting motif; Tyr: Tyr-based sorting motif; diGlu HIV-Nef: a two-Glu motif in HIV-Nef protein; KKXX: di-Lys ER;
FF: di-Phe: sorting motifs in the early secretory pathway; End COP: endosomal COP-I; Golgi COP: Golgi COP-I; PLD: phospholipase D;
PA: phosphatidic acid; PIs: phosphatidylinositides.
aF. Gu and J. Gruenberg, unpublished.
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